81 FR 23499 - Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing; Correction
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration Federal Register Volume 81, Issue 77 (April 21, 2016)
Food and Drug Administration
Federal Register Volume 81, Issue 77 (April 21, 2016)
| Page Range | 23499-23499 | |
| FR Document | 2016-09265 |
[Federal Register Volume 81, Number 77 (Thursday, April 21, 2016)] [Notices] [Page 23499] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-09265] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-0832] Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice of opportunity for hearing; correction. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on April 12, 2016 (81 FR 21559). The document announced an opportunity for a hearing on FDA's Center for Veterinary Medicine's proposal to withdraw approval of all new animal drug applications providing for use of carbadox in medicated swine feed and contained an incorrect telephone number for the individual to be contacted for further information. The address for Phibro Animal Health Corp. was also incorrect. This document corrects those errors. FOR FURTHER INFORMATION CONTACT: Vernon Toelle, Center for Veterinary Medicine (HFV-234), 7519 Standish Pl., Rockville, MD 20855, 240-402- 7001. SUPPLEMENTARY INFORMATION: In FR Doc. 2016-08327, appearing on page 21559 in the Federal Register of Tuesday, April 12, 2016, the following corrections are made: 1. On page 21560, in the second column, in the FOR FURTHER INFORMATION CONTACT paragraph, the telephone number is corrected to read ``240-402-7001''. 2. On page 21560, in the third column, in the first paragraph, the address for Phibro Animal Health Corp. is corrected to read ``GlenPointe Centre East, 3d floor, 300 Frank W. Burr Blvd., suite 21, Teaneck, NJ 07666''. 3. On page 21572, in the first column, in the third paragraph, the address for Phibro Animal Health Corp. is corrected to read ``GlenPointe Centre East, 3d floor, 300 Frank W. Burr Blvd., suite 21, Teaneck, NJ 07666''. Dated: April 18, 2016. Tracey Forfa, Acting Director, Center for Veterinary Medicine. [FR Doc. 2016-09265 Filed 4-20-16; 8:45 am] BILLING CODE 4164-01-P
![Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices 23499
Background and Brief Description and participation in the optional information about adults 18 years and
question modules. Both the core survey older. BRFSS topics include health risk
CDC is requesting OMB approval to and the optional modules are updated behaviors, health conditions, and
revise information collection for the annually.
Behavioral Risk Factor Surveillance preventive health practices that are
CDC requests OMB approval to associated with chronic diseases,
System (BRFSS). The BRFSS is a incorporate a limited annual field test
nationwide system of annual, cross- infectious diseases, and injury. This
into the BRFSS clearance. Field testing information is used by state and local
sectional telephone health surveys will be conducted approximately 5–8
sponsored by CDC. BRFSS coordinators health departments to plan and evaluate
months in advance of the principal
in health departments in U.S. states, public health programs at the state or
BRFSS survey. Field tests are used to
territories, and the District of Columbia sub-state level. In addition, CDC makes
identify problems with new or updated
(collectively referred to as states) questions, instrument documentation or annual BRFSS data sets available for
collaborate with CDC on questionnaire instructions, software errors, or other public use and provides guidance on
content and survey administration. implementation issues. Field tests are statistically appropriate uses of the data.
An independent sample of adult, non- typically conducted in one state. Field test results will not be
institutionalized respondents is drawn Addition of the annual field test will incorporated into the analytic data sets.
each for each state and is based on the increase the estimated annualized Field test results are used exclusively to
state’s parameters for state-level or sub- number of responses by 900 and the inform the development of the
state analysis. Each state’s annual estimated annualized burden by 382 upcoming year’s BRFSS questionnaire
questionnaire is based on a common hours. These estimates include and the technical assistance that CDC
core that is administered by all states. In allocations for both respondent provides to states.
addition, CDC provides support for screening and completion of the field
standardized optional modules that test survey. Each year CDC will use the OMB approval is requested for three
states can use to collect customized Change Request mechanism to request years. Participation in the BRFSS is
content. Information collection is OMB approval of the annual Field Test voluntary and there are no costs to
conducted in a continuous, three-part Supplement. respondents other than their time. The
telephone interview process: Screening, CDC and the states will continue to total estimated annualized burden hours
participation in core BRFSS questions, use BRFSS data to produce state-level are 256,297.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per
Type of respondents Form name responses per
respondents response
respondent (in hr)
U.S. General Population ................................. Landline Screener .......................................... 440,486 1 1/60
Cell Phone Screener ...................................... 223,334 1 1/60
Field Test Screener ........................................ 400 1 1/60
Adults ≥18 Years ............................................ Core Survey ................................................... 494,650 1 15/60
Optional Modules ........................................... 484,757 1 15/60
Field Test Survey ........................................... 500 1 45/60
Leroy A. Richardson, notice that appeared in the Federal INFORMATION CONTACT paragraph, the
Chief, Information Collection Review Office, Register on April 12, 2016 (81 FR telephone number is corrected to read
Office of Scientific Integrity, Office of the 21559). The document announced an ‘‘240–402–7001’’.
Associate Director for Science, Office of the opportunity for a hearing on FDA’s
Director, Centers for Disease Control and 2. On page 21560, in the third
Center for Veterinary Medicine’s column, in the first paragraph, the
Prevention.
proposal to withdraw approval of all
[FR Doc. 2016–09189 Filed 4–20–16; 8:45 am] address for Phibro Animal Health Corp.
new animal drug applications providing
is corrected to read ‘‘GlenPointe Centre
BILLING CODE 4163–18–P for use of carbadox in medicated swine
feed and contained an incorrect East, 3d floor, 300 Frank W. Burr Blvd.,
telephone number for the individual to suite 21, Teaneck, NJ 07666’’.
DEPARTMENT OF HEALTH AND be contacted for further information. 3. On page 21572, in the first column,
HUMAN SERVICES The address for Phibro Animal Health in the third paragraph, the address for
Food and Drug Administration Corp. was also incorrect. This document Phibro Animal Health Corp. is corrected
corrects those errors. to read ‘‘GlenPointe Centre East, 3d
[Docket No. FDA–2016–N–0832] floor, 300 Frank W. Burr Blvd., suite 21,
FOR FURTHER INFORMATION CONTACT:
Vernon Toelle, Center for Veterinary Teaneck, NJ 07666’’.
Phibro Animal Health Corp.; Carbadox
in Medicated Swine Feed; Opportunity Medicine (HFV–234), 7519 Standish Pl., Dated: April 18, 2016.
for Hearing; Correction Rockville, MD 20855, 240–402–7001. Tracey Forfa,
jstallworth on DSK7TPTVN1PROD with NOTICES
AGENCY: Food and Drug Administration, SUPPLEMENTARY INFORMATION: In FR Doc. Acting Director, Center for Veterinary
HHS. 2016–08327, appearing on page 21559 Medicine.
in the Federal Register of Tuesday, [FR Doc. 2016–09265 Filed 4–20–16; 8:45 am]
ACTION: Notice of opportunity for
April 12, 2016, the following corrections
hearing; correction. BILLING CODE 4164–01–P
are made:
SUMMARY: The Food and Drug 1. On page 21560, in the second
Administration (FDA) is correcting a column, in the FOR FURTHER
VerDate Sep<11>2014 13:27 Apr 20, 2016 Jkt 238001 PO 00000 Frm 00044 Fmt 4703 Sfmt 9990 E:\FR\FM\21APN1.SGM 21APN1](https://thefederalregister.org/doc/81_FR_23576/page/1.svg)
Document Created: 2016-04-21 01:17:07
Document Modified: 2016-04-21 01:17:07
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of opportunity for hearing; correction. | |
| Contact | Vernon Toelle, Center for Veterinary Medicine (HFV-234), 7519 Standish Pl., Rockville, MD 20855, 240-402- 7001. | |
| FR Citation | 81 FR 23499 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR